Today, Genworth Financial, Inc. (NYSE: GNW), a leader in long term care issues for 35 years, announced a brand new caregiving support service, available to AARP members and designed to meet the needs of AARP’s millions of members nationwide. AARP® Caregiving Help and Advice from Genworth breaks new ground by becoming the first national service endorsed by AARP to integrate care assessment, care planning and provider matching.
To view Multmedia News Release, go to http://www.multivu.com/mnr/54343-genworth-aarp-members-caregiving-service-help-and-advice
The world became less peaceful for the second consecutive year, according to the fourth annual Global Peace Index (GPI) published today. As the global economy continues to falter, this year’s data shows an intensification of conflicts and growing instability linked to the downturn that began in 2008, with several countries seeing sharp increases in homicides, violent demonstrations and fear of crime.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/iep/42434/
Billie Jean King is joining the Arthritis Foundation, the Ad Council and the United States Tennis Association (USTA) to launch a new public service campaign to fight arthritis—the leading cause of disability in America. The ads, which debut at the US Open today, highlight the power of movement and activities, such as tennis, walking, biking and swimming, as weapons in the fight against osteoarthritis (OA). They will premiere on TV screens and PA announcements and in signage and collateral materials throughout the US Open in the Arthur Ashe Stadium.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51773-ad-council-fight-arthritis-pain
Volkswagen of America, Inc., today announced the world debut of the all-new Passat, a transformational car in Volkswagen’s ambitious growth plan for the U.S. market.
Designed in Germany and made in America, the Passat was developed as a larger vehicle with premium features and handling characteristics that will perfectly match it with the tastes and lifestyles of Americans. It will be built in Chattanooga, Tenn., at the world’s newest, most advanced and environmentally responsible auto assembly plant.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/vw/40221/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu,’ even when given late in the course of illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/outcome/46648/
Kimberly-Clark’s Huggies® Brand today announced its second class of MomInspired™ grant recipients, unveiling nine unique ideas that address a diverse range of parenting, baby and child care product and service solutions. Huggies’ MomInspired grant program provides seed capital and resources to help fund women-owned business startups and new product innovations inspired by personal motherhood challenges and experiences.
In the two years of the program, Huggies MomInspired has solicited nearly 1,000 product and service idea applications addressing unmet parenting needs, and has awarded $315,000 in grant money – $15,000 each to 21 inventive women.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53278-huggies-second-annual-mominspired-grants-to-nine-mom-product-inventors
Travis Air Force Base squadron members took to the sky at Six Flags Discovery Kingdom today, as the first “flyers” to experience the park’s newest thrill ride, SkyScreamer. SkyScreamer, which opens to the public on Friday, May 27, is the latest sensation in tower rides, and takes the concept of spinning round and round to a new level of thrills. The lofty attraction joins the park’s unique array of rides, shows and interactive animal experiences.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/sixflags/49942/
The American Cancer Society, the nation's largest voluntary health organization, today will launch a new nationwide movement to shine the spotlight on a sobering statistic: one in three women will get cancer in her lifetime. Choose You (www.ChooseYou.com) is designed to inspire women to take action and put their health first in order to stay well and help prevent cancer.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/americancancersociety/43827/
In recognition of Pain Awareness Month (PAM), the Let’s Talk Pain Coalition today launched the Pain Medication Safety Series, an online video series featuring candid dialogues between health care professionals, people with pain and their caaregivers about the safe and appropriate use of pain therapies. A complete listing of episodes with descriptions is available at www.letstalkpain.com/painmedsafety.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/letstalkpain/45730/
The MLX90620 FIRray sensing device from Melexis, utilizes the company’s innovative non-contact temperature measurement technology to create a highly cost-effective thermography solution. Covering a -20°C to 300°C temperature range, this 16 x 4 element far infrared (FIR) thermopile sensor array produces a map of heat values for the target area in real time, avoiding the need to scan the area with a single point sensor or to use of an expensive microbolometer device.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/melexis/53790
As soon as you start feeling run down or have other flu-like symptoms, take Oscillococcinum.
Oscillo® is supported by published clinical studies, as well as more than 65 years of use throughout the world.
-Clinical studies show that Oscillo reduces the severity and duration of flu-like symptoms such as headache, body aches, chills and fever
-Great taste and convenient to take
-No side effects; no drug interactions; non-drowsy
-Safe for everyone 2 years of age and older
To view Multimedia News Release, go to http://www.multivu.com/players/English/45775-Boiron-Oscillococcinum/
